AXIM

Axim Biotechnologies (QB) Stock Price

0.705
-0.0435 (-5.81%)
0.705
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Small Cap Pro
Monthly Subscription
for only
$49.05
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
VAT not included
Company Name Stock Ticker Symbol Market Type
Axim Biotechnologies Inc (QB) AXIM OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
-0.0435 -5.81% 0.705 0.67 0.72 0.67 0.7485 16:59:04
Bid Price Ask Price Spread Spread % News
0.70 0.755 0.055 7.28% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
203 168,972 $ 0.700832 $ 118,421 1,033,401 0.10 - 1.44
Last Trade Time Type Quantity Stock Price Currency
15:59:19 100 $ 0.705 USD

Axim Biotechnologies (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 92.86M 131.71M 37.38M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
3.26k $ - 0.00% - -

more financials information »

Axim Biotechnologies (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AXIM Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.80630.900.670.7960709300,873-0.1013-12.56%
1 Month0.741.440.600.88676941,625,287-0.035-4.73%
3 Months0.1631.440.15140.70461921,099,8890.542332.52%
6 Months0.29531.440.100.595754632,9090.4097138.74%
1 Year0.701.440.100.5838866353,6070.0050.71%
3 Years6.2010.290.101.13172,984-5.50-88.63%
5 Years0.600119.800.0612.03128,5560.104917.48%

Axim Biotechnologies (QB) Description

Founded in 2014, AXIM(R) Biotechnologies, Inc. (AXIM) is a vertically integrated research and development company focused on changing diagnosis and treatment for oncology and SARS-CoV-2 (COVID-19). AXIM’s NeuCovixTM is the first rapid diagnostic test measuring levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells. Additionally, the Company is developing rapid diagnostic tests for the early detection of cancer and proprietary small molecules drugs to treat cancer and block metastasis. For more information, please visit www.AXIMBiotech.com.


Your Recent History
USOTC
AXIM
Axim Biote..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.